
HealthcareCybersecurityBiotech & Life SciencesInfrastructure & CloudConsumerHardware & SemiconductorsFood & AgricultureLogistics & Supply ChainClimate & EnergyRobotics & AutomationManufacturing
Brabantse Ontwikkelings Maatschappij (BOM) focuses its investments on innovative and scalable startups and scale-ups within the Brabant region of the Netherlands. The firm targets sectors such as High-Tech Systems and Software, Agri-food, Life Sciences & Health, sustainable energy, and other promising key technologies, aiming to foster economic growth and a sustainable future for the region.
Deal activity increased 350% year-over-year (9 deals in the last 12 months). Their most common stage is series-b (40% of deals). Average disclosed round size is $28.8M (across 14 rounds with reported amounts).
Portfolio
15
Fund Size
$870M
Top Stage
Series B
Last 12 Mo
9
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
15 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Series B | $83.1M | Mar 2026 | |
| XXyall | Unknown | $7.6M | Feb 2026 |
| CCoolSem Technologies | Pre-Seed | — | Jan 2026 |
| SShanX Medtech | Seed | $15M | Jan 2026 |
| SSandGrain | Series A | $13.5M | Dec 2025 |
| RRevyve | Series B | $24M | Sep 2025 |
| TTracXon | Seed | $4.8M | Sep 2025 |
| SSalvia Bioelectronics | Series B | $60M | May 2025 |
| Seed | $15M | May 2025 | |
| Series B | $85M | Dec 2024 | |
| CCarbyon | Series A | $15.3M | Sep 2024 |
| Series C | $32M | Jan 2024 | |
| Series B | $38M | Oct 2023 | |
| Unknown | $5.5M | Nov 2022 | |
| Series B | $4M | Jun 2020 |
Top Co-Investors
Invest-NL10 shared
Innovation Industries6 shared
Oost NL2 shared
BioGeneration Ventures2 shared
imec.xpand2 shared
HTGF2 shared
Borski Fund1 shared
NextGen Venture Partners1 shared
Capricorn1 shared
Siemens Financial Services1 shared
Omnes Capital1 shared
Lowercarbon Capital1 shared
ALIAD1 shared
INKEF Capital1 shared
Dolby Family Ventures1 shared
Thuja Capital1 shared
PGGM1 shared
Rubio Impact Ventures1 shared
Johnson & Johnson Innovation1 shared
Last updated: 12 April 2026